These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34486482)

  • 41. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance.
    Huang X; Gan G; Wang X; Xu T; Xie W
    Autophagy; 2019 Jul; 15(7):1258-1279. PubMed ID: 30786811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair.
    Liang DH; Choi DS; Ensor JE; Kaipparettu BA; Bass BL; Chang JC
    Cancer Lett; 2016 Jul; 376(2):249-58. PubMed ID: 27060208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence.
    Li Y; Li X; Li X; Zhong Y; Ji Y; Yu D; Zhang M; Wen JG; Zhang H; Goscinski MA; Nesland JM; Suo Z
    Oncotarget; 2016 Aug; 7(33):53837-53852. PubMed ID: 27462778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Knockdown of FBP1 enhances radiosensitivity in prostate cancer cells by activating autophagy.
    Li XR; Zhou KQ; Yin Z; Gao YL; Yang X
    Neoplasma; 2020 Sep; 67(5):982-991. PubMed ID: 32453596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.
    Chang L; Graham PH; Hao J; Ni J; Bucci J; Cozzi PJ; Kearsley JH; Li Y
    Cell Death Dis; 2013 Oct; 4(10):e875. PubMed ID: 24157869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthetic lethality of glutaminolysis inhibition, autophagy inactivation and asparagine depletion in colon cancer.
    Li J; Song P; Zhu L; Aziz N; Zhou Q; Zhang Y; Xu W; Feng L; Chen D; Wang X; Jin H
    Oncotarget; 2017 Jun; 8(26):42664-42672. PubMed ID: 28424408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development.
    Wang Q; Hardie RA; Hoy AJ; van Geldermalsen M; Gao D; Fazli L; Sadowski MC; Balaban S; Schreuder M; Nagarajah R; Wong JJ; Metierre C; Pinello N; Otte NJ; Lehman ML; Gleave M; Nelson CC; Bailey CG; Ritchie W; Rasko JE; Holst J
    J Pathol; 2015 Jul; 236(3):278-89. PubMed ID: 25693838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program.
    Aguilar E; Marin de Mas I; Zodda E; Marin S; Morrish F; Selivanov V; Meca-Cortés Ó; Delowar H; Pons M; Izquierdo I; Celià-Terrassa T; de Atauri P; Centelles JJ; Hockenbery D; Thomson TM; Cascante M
    Stem Cells; 2016 May; 34(5):1163-76. PubMed ID: 27146024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-145 inhibits glutamine metabolism through c-myc/GLS1 pathways in ovarian cancer cells.
    Li J; Li X; Wu L; Pei M; Li H; Jiang Y
    Cell Biol Int; 2019 Aug; 43(8):921-930. PubMed ID: 31115975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brain Tumor Stem Cell Dependence on Glutaminase Reveals a Metabolic Vulnerability through the Amino Acid Deprivation Response Pathway.
    Restall IJ; Cseh O; Richards LM; Pugh TJ; Luchman HA; Weiss S
    Cancer Res; 2020 Dec; 80(24):5478-5490. PubMed ID: 33106333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of CD133
    Güler G; Guven U; Oktem G
    Analyst; 2019 Mar; 144(6):2138-2149. PubMed ID: 30742170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells.
    Cojoc M; Peitzsch C; Kurth I; Trautmann F; Kunz-Schughart LA; Telegeev GD; Stakhovsky EA; Walker JR; Simin K; Lyle S; Fuessel S; Erdmann K; Wirth MP; Krause M; Baumann M; Dubrovska A
    Cancer Res; 2015 Apr; 75(7):1482-94. PubMed ID: 25670168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells.
    Marhold M; Tomasich E; El-Gazzar A; Heller G; Spittler A; Horvat R; Krainer M; Horak P
    Mol Cancer Res; 2015 Mar; 13(3):556-64. PubMed ID: 25349289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy.
    Leão R; Domingos C; Figueiredo A; Hamilton R; Tabori U; Castelo-Branco P
    Urol Int; 2017; 99(2):125-136. PubMed ID: 28142149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cancer stem-cell signaling network and resistance to therapy.
    Carnero A; Garcia-Mayea Y; Mir C; Lorente J; Rubio IT; LLeonart ME
    Cancer Treat Rev; 2016 Sep; 49():25-36. PubMed ID: 27434881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of guanosine monophosphate synthetase (GMPS) blocks glutamine metabolism and prostate cancer growth.
    Wang Q; Guan YF; Hancock SE; Wahi K; van Geldermalsen M; Zhang BK; Pang A; Nagarajah R; Mak B; Freidman N; Horvath LG; Turner N; Holst J
    J Pathol; 2021 Jun; 254(2):135-146. PubMed ID: 33768538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pyruvate carboxylase is required for glutamine-independent growth of tumor cells.
    Cheng T; Sudderth J; Yang C; Mullen AR; Jin ES; Matés JM; DeBerardinis RJ
    Proc Natl Acad Sci U S A; 2011 May; 108(21):8674-9. PubMed ID: 21555572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
    Kumar D; Gupta D; Shankar S; Srivastava RK
    Oncotarget; 2015 Feb; 6(5):3280-91. PubMed ID: 25682864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of β-catenin in cancer stem-like cells.
    Zhang Q; Huang H; Liu A; Li J; Liu C; Sun B; Chen L; Gao Y; Xu D; Su C
    EBioMedicine; 2019 Apr; 42():397-407. PubMed ID: 30904606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging role of lipid metabolism alterations in Cancer stem cells.
    Yi M; Li J; Chen S; Cai J; Ban Y; Peng Q; Zhou Y; Zeng Z; Peng S; Li X; Xiong W; Li G; Xiang B
    J Exp Clin Cancer Res; 2018 Jun; 37(1):118. PubMed ID: 29907133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.